Concepedia

Author

J. Buesa

Hospital Universitario Central de Asturias

Also Known As

J BUESA, J Buesa, J M Buesa, J. Buesa, J. M. Buesa, J.M Buesa, J.M. Buesa, JOSÉ M. BUESA, Jose Buesa, Jose M. Buesa

75

Publications

4.7K

Citations

28

H-Index

56

Concepts

All Affiliations

Hospital Universitario Central de AsturiasInstituto de Investigación Sanitaria del Principado de AsturiasEuropean Organisation for Research and Treatment of CancerThe Netherlands Cancer InstituteFondazione IRCCS Istituto Nazionale dei Tumori
JB

About

J. Buesa is an author at Hospital Universitario Central de Asturias specializing in medicine, oncology, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

20

24

1.8K

2

Health Sciences

3

3

64

3

Biochemistry

3

3

96

4

Cell Biology

2

2

194

5

Natural Sciences

1

1

13

J. Buesa

×

39

Publications

4.5K

Citations

27

H-Index

YearCitations

Prognostic Factors for the Outcome of Chemotherapy in Advanced Soft Tissue Sarcoma: An Analysis of 2,185 Patients Treated With Anthracycline-Containing First-Line Regimens—A European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group Study

M. van Glabbeke, A.T. van Oosterom, J. Wolter Oosterhuis,

Journal of Clinical Oncology

1999

565

Doxorubicin versus CYVADIC versus doxorubicin plus ifosfamide in first-line treatment of advanced soft tissue sarcomas: a randomized study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

Armando Santoro, T Türsz, Henning T. Mouridsen,

Journal of Clinical Oncology

1995

526

A randomised phase II study on neo-adjuvant chemotherapy for ‘high-risk’ adult soft-tissue sarcoma

E. Gortzak, Alberto Azzarelli, J. Buesa,

European Journal of Cancer

2001

376

Deletions Affecting Codons 557-558 of the <i>c</i>-<i>KIT</i> Gene Indicate a Poor Prognosis in Patients With Completely Resected Gastrointestinal Stromal Tumors: A Study by the Spanish Group for Sarcoma Research (GEIS)

Javier Martín‐Broto, Andrés Poveda, Antonio Llombart‐Bosch,

Journal of Clinical Oncology

2005

350

Randomized Phase II Study Comparing Gemcitabine Plus Dacarbazine Versus Dacarbazine Alone in Patients With Previously Treated Soft Tissue Sarcoma: A Spanish Group for Research on Sarcomas Study

Xavier García del Muro, Antonio López–Pousa, Joan Maurel,

Journal of Clinical Oncology

2011

293

Surgical treatment of lung metastases: The European Organization for Research and Treatment of Cancer-Soft Tissue and Bone Sarcoma Group study of 255 patients

A.N. van Geel, Ugo Pastorino, K. W. Jauch,

Cancer

1996

283

Adjuvant CYVADIC chemotherapy for adult soft tissue sarcoma--reduced local recurrence but no improvement in survival: a study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group.

V. Bramwell, Jacques Rouëssé, William P. Steward,

Journal of Clinical Oncology

1994

249

Randomized Phase II Study of Docetaxel Versus Doxorubicin in First- and Second-Line Chemotherapy for Locally Advanced or Metastatic Soft Tissue Sarcomas in Adults: A Study of the European Organization for Research and Treatment of Cancer Soft Tissue and Bone Sarcoma Group

Jaap Verweij, Siow Ming Lee, Wlodzimir Ruka,

Journal of Clinical Oncology

2000

170

Adriamycin versus epirubicin in advanced soft tissue sarcomas. A randomized phase II/phase III study of the EORTC soft tissue and bone sarcoma group

Henning T. Mouridsen, Lars Bastholt, R. Somers,

European Journal of Cancer and Clinical Oncology

1987

154

Protein Kinase C θ Is Highly Expressed in Gastrointestinal Stromal Tumors But Not in Other Mesenchymal Neoplasias

Pilar Blay, Aurora Astudillo, J. Buesa,

Clinical Cancer Research

2004

138

Page 1